Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Status Completed

Clinical Trial Summary

This protocol will compare topical paromomycin to standard intralesional (IL) antimony (Sb) to placebo for L braziliensis in Bolivia.

Clinical Trial Description

Patients will be randomized between Paromomycin cream applied topically once daily for 20 days (group 1--40 patients), pentamidine administered intralesionally at 120 ug/mm2 on days 1, 3, 5 (group 2-20 patients), and cream vehicle applied topically once daily for 20 days (group 3-20 patients). After treatment, all patients will be followed for 1, 3, and 6 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03096457
Study type	Interventional
Source	Fundacion Nacional de Dermatologia
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	April 15, 2017
Completion date	April 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01140191` - Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis	Phase 2
Completed	`NCT03999970` - A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol	N/A
Completed	`NCT00111553` - Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis	Phase 1
Recruiting	`NCT03762070` - Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru
Completed	`NCT02894008` - A Study of a New Leishmania Vaccine Candidate ChAd63-KH	Phase 2
Completed	`NCT03303898` - ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -	N/A
Recruiting	`NCT05094908` - Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis	Phase 1
Completed	`NCT01083576` - Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama	Phase 2
Completed	`NCT03445897` - Miltefosine Plus IL Pentamidine for Bolivian CL	Phase 2
Withdrawn	`NCT04072874` - Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.	Phase 1/Phase 2
Completed	`NCT01032382` - Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)	Phase 2
Completed	`NCT00480883` - Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol	N/A
Recruiting	`NCT05708625` - Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis	Phase 3
Completed	`NCT04841239` - Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis	N/A
Completed	`NCT00469495` - Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis	N/A
Completed	`NCT03294161` - Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis	Phase 2
Completed	`NCT04888130` - Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)
Completed	`NCT03969134` - A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL	Phase 2
No longer available	`NCT01641796` - Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
No longer available	`NCT00508963` - Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis